2018 ASM Election: Candidates 


Board of Directors, Early Career Scientist

Board of Directors, International Scientist

Council on Microbial Sciences, Early Career Scientist

Council on Microbial Sciences, International Scientists

Click here to vote: https://secure.intelliscaninc.net/asm/2018/

Your ASM member number has changed.  If you haven't received notification of your ID, please contact service@asmusa.org

President-Elect - Select One

Professor, Addison B. Scoville, Jr.
Chair in Medicine, and Director, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennesse

ad confused 3

Dr. Aronoff received his Bachelor of Science degree in Microbiology (summa cum laude) from Indiana University and his Medical Degree from Tufts University. Following internship and residency training in Internal Medicine at Vanderbilt University, Dr. Aronoff completed both a clinical fellowship in Infectious Diseases and a research fellowship in Clinical Pharmacology there. He then moved to join the faculty in Infectious Diseases at the University of Michigan where he also completed a research postdoctoral fellowship in Immunology.

Professional Experience:
Dr. Aronoff joined the faculty of the University of Michigan in 2002. He rose to the rank of Associate Professor with tenure in the Departments of Internal Medicine and Microbiology and Immunology. He remained there until 2013, when he was recruited back to Vanderbilt University. Dr. Aronoff has a secondary faculty appointment in the Department of Pathology, Microbiology, and Immunology and is an adjunct faculty member in the Department of Microbiology and Immunology at Meharry Medical College.

ASM Activities:
Dr. Aronoff served as Vice Chair for the ASM Microbe annual meeting in 2016, 2017 and will serve this role in 2018. He was a member of the ASM ICAAC Program Committee from 2008-2015 and Directed the ICAAC Fellows Program from 2011-2015. From 2013-2014 he served on the ASM Strategic Planning Committee and in 2015 the Hilleman Award Selection Committee. He has served on the Membership Tiers Task Force and is currently a member of the Awards Selection Committee and the Appointments Committee. Dr. Aronoff was elected as Fellow in the American Academy of Microbiology in 2017.

Over 160 publications indexed on PubMed, found here: https://www.ncbi.nlm.nih.gov/pubmed/?term=aronoff+dm

Research Interests:
The Aronoff lab studies host-microbial interactions with a focus on bacterial infections and innate immunity. His primary contributions have been in defining the role for macrophages in host defense during infections caused by Gram positive bacteria such as clostridia and streptococci. Currently his lab is focused on understanding the mechanisms of disease pathogenesis in both Group B Streptococcus infections during pregnancy and in Clostridium difficile infections of the gastrointestinal tract.

Candidate’s Statement:
What an exhilarating time to be a microbial scientist! I am so honored to be a candidate for President-Elect of our Society. By way of introduction, I hold a Bachelor of Science degree in Microbiology from Indiana University and a Medical Degree from Tufts University. Following residency training in Medicine at Vanderbilt University, I completed both a clinical fellowship in Infectious Diseases and a research fellowship in Clinical Pharmacology, also at Vanderbilt. I then studied innate immunity and bacterial pathogenesis during a postdoctoral fellowship at the University of Michigan, where I launched my independent faculty career. My laboratory research remains focused on the host-microbial interface, and I have been back at Vanderbilt University as Director of the Division of Infectious Diseases since 2013. I have a strong background in service, evidenced by my membership on federal and non-federal grant review study sections, editorial roles for several academic journals, and service as President of the Anaerobe Society of the Americas.

I am a proud Fellow of the American Academy of Microbiology and have been an active volunteer for ASM for the past 10 years, serving on the programming committees for the Interscience Conference on Antimicrobials and Chemotherapy (ICAAC) and for the ASM Microbe meeting (where I am Vice-Chair). I have served on key ASM committees, including the Strategic Planning Committee, the Membership Tiers Task Force, the Awards Selection Committee, and the Appointments Committee. I also directed the ICAAC Fellows Program, focused on early career development, for five years.

ASM has been on the forefront of the microbial sciences for nearly 120 years and is vital as ever. The microbial sciences are changing rapidly, impacted by climate change, population expansion, the crisis of antimicrobial resistance, new epidemics, the development of innovative tools for high-resolution imaging of the microbial world, the rise of “big data” and systems biology, and significant threats to research and education funding. What hasn’t changed? The strong dedication of the ASM to lead from the front of the microbial sciences. ASM has been a tremendous voice for the microbial sciences and that it is a high priority for me, to make sure that it maintains and even increases its ability to advocate for its members.

Other high priority goals for me are to focus on enhancing diversity (both in our scientific portfolio and our membership) and fostering early career development. Mentorship is important, and is something I will seek to enhance. I will be an advocate for ASM to catalyze trans-disciplinary collaborations in discovery and education. My experiences at ASM have given me a keen appreciation for the critical role that meeting and communicating play in accelerating the microbial sciences. The ways through which we share knowledge, including in person and through the internet are likely to change significantly in the near future and I want to help ASM innovate in this space. Thank you for considering me as a candidate to serve the ASM at this high level.

 back to top

MD, D(ABMM), FIDSA, FACP, F(AAM), Chair, Division of Clinical Microbiology; Director, Infectious Diseases Research Laboratory; Co-Director, Clinical Bacteriology Laboratory; Professor of Microbiology and Medicine, Elizabeth P. and Robert E. Allen Professor of Individualized Medicine, Mayo Clinic, Rochester, Minnesota

ad confused 3

Princeton University, BA Chemistry, 1985; McGill University, MD, 1989; Mayo Clinic, Internal Medicine Residency, Infectious Diseases and Clinical Microbiology Fellowships, 1989-1996 

Professional Experience:
96-Present Faculty, Mayo Clinic (Assistant Professor, 96-00; Associate Professor, 00-06; Professor, 06-Present); 96-Present Member, Infectious Diseases Research Committee, Mayo Clinic; 98-Present Multiple NIH Study Sections and Special Emphasis Panels; 00-09 Chair, Infectious Diseases Research, Mayo Clinic; 01-Present Director, Microbiology, Mayo Medical School (MMS); 04-06 Member, IDSA Publications Committee; 07-12 Program Director, Clinical Microbiology Fellowship Program, Mayo Clinic; 07-10 Member, Student Promotions Committee, MMS; 07-Present Director, Clinical Bacteriology Laboratory, Mayo Clinic (Co-Director 15-Present); 07-Present Basic Science Theme Leader, MMS; 09-Present; USMLE Committees: Microbiology and Immunology Test Development (Member 09-14; Chair, 14-17), Item Review (Member 15-present); 09-Present Member, Mayo Foundation Conflict of Interest Review Board; 10-15 Member, Research Finance Subcommittee, Mayo Clinic; 10-13 Member, IDSA’s Annual Meeting Planning Committee; 11-Present Chair, Division of Clinical Microbiology, Mayo Clinic; 13-15 Chair, Diagnostics and Devices Subcommittee, Antibacterial Resistance Leadership Group (ARLG); 13-Present Member, Mentoring Committee, ARLG; 13-14 Advisor, Clinical and Laboratory Standards Institute (CLSI), Subcommittee on Antimicrobial Susceptibility Testing (AST); 15-Present Director of Diagnostics and Master Protocol, ARLG; 15-Present Member, CLSI, Subcommittee on AST; 16-Present Member, Research Space and Equipment Subcommittee, Mayo Clinic; 16-Present Associate Editor, Clinical Infectious Diseases; 17-20 Member, National Advisory Allergy and Infectious Diseases Council

ASM Activities:
92-Present Member; 99-07 Editorial Board, Journal of Clinical Microbiology; 02-07 ICAAC Program Planning Committee (ICAAC/IDSA Committee 2007); 01-10 Editorial Board, Antimicrobial Agents and Chemotherapy; 02-13 Editorial Board, Clinical Microbiology Reviews; 09-19 Associate Editor, Journal of Clinical Microbiology; 10-13 Award Nominations Committee; 11-18 ASM Microbe Program Planning Committee (Vice Chair 13-15; Co-Chair 16-18); 2012 Fellow - American Academy of Microbiology; 2013 Meetings Strategic Planning; 2014 Communications Strategic Planning; 2014 Bill and Melinda Gates Foundation-ASM Meeting; 2015 BD Award for Research in Clinical Microbiology Recipient; 15-17 Clinical Awards Selection Committee Member; 2016 JCM/ASM China Publications Event; 2017-2018 Board of Directors Member (elected)

>250 publications http://www.ncbi.nlm.nih.gov/sites/myncbi/robin.patel.2/bibliograpahy/47618838/public/?sort=date&direction=ascending

Research Interests:
My research focuses on microbial biofilms, antibacterial resistance and clinical bacteriology diagnostic testing. I have a longstanding interest in novel strategies for detection and management, and understanding the pathogenesis of, biofilm-associated orthopedic infection, especially prosthetic joint infection (PJI). I have developed a number of diagnostic assays for PJI and have an active research program investigating novel PJI treatment and diagnostic strategies. My group also works on antibacterial resistance, performing phenotypic and genotypic studies of resistance in Gram-positive and Gram-negative bacteria. We have described new types of resistance. In addition, I have a longstanding interest in animal models of infection, as means for evaluating novel antimicrobial agents and for studying infection pathogenesis. Many of the models we use were developed in my laboratory. Finally, I have a track record of developing novel diagnostic assays for clinical practice.

Candidate’s Statement:
I have been an American Society for Microbiology member for 25 years, over which time I have been an active participant in and contributor to ASM’s journals, meetings and other activities. In addition to avidly reading numerous ASM journals, I have published my science in Infection and Immunity, Antimicrobial Agents and Chemotherapy (AAC), Clinical Microbiology Reviews (CMR) and the Journal of Clinical Microbiology (JCM). I have had the pleasure of serving on the editorial boards of the JCM, AAC and CMR and am a current Associate Editor for the JCM. I made my first major scientific presentation at an ICAAC meeting in the early 1990’s (and can remember it as if it were yesterday). Since the 1990’s, I have attended the ASM General Meeting and ICAAC on a regular basis, along with a number of other ASM meetings (e.g., Conferences on Enterococci, Streptococcal Genetics and Biofilms, Clinical Virology Symposium). From 2002 to 2007, and from 2011 to 2015, I was a member of the ICAAC Program Committee, serving as Vice Chair for the 2013 to 2015 meetings. I have served as Co-Chair of the ASM Microbe Program Committee since its inception; 2018 will be my final year in this capacity. In my roles as Vice and Co-Chairs of the two meetings, I have participated in strategic planning meetings, alongside relationship building meetings between ASM and Industry and Foundations. I have been involved in a number of award selection processes for ASM over the past several years, and in 2015 was honored to receive the ASM BD Award for Research in Clinical Microbiology.  Finally, I currently serve as a member of ASM’s Board of Directors.

ASM is a Society I strongly support and believe in, and one that has supported me. My goal in running for the position of President Elect is to give back to the Society by providing leadership, mentorship, oversight and direction to the Society. I value responsiveness and transparency in leadership. Our fields and ASM are changing and will continue to do so. The Society has an amazing 47,000 members worldwide, who have diverse backgrounds and needs. In the increasingly multidisciplinary scientific world of today, ASM is ideally positioned to provide a scientific home to microbiologists of varying backgrounds, as well as to provide a base for individual communities of microbial scientists, educators and clinicians, and the cross-linking of their communities. ASM’s main goal has to be to support its members, through its meetings, publications, training opportunities, and advocacy. ASM is also a Society in which its members can get involved, as I have; these “opportunities” need to grow and be made more visible to ASM members. ASM has a unique position among microbiology societies and one that must be nurtured to best support its members in a changing world. If elected, I will open my e-mail Inbox to any member who has ideas or thoughts about what ASM should be doing to support and engage its membership.

back to top

Board of Directors, Early Career Scientist - Select one

Director of the Science Education  Program and Community Partnerships of Ciencia Puerto Rico (CienciaPR)



Dr. Díaz completed a Bachelor and Master Degrees in Biology, at the University of Puerto Rico, Mayagüez. Then, she earned her PhD in Molecular, Cellular and Developmental Biology at The Ohio State University, where she studied intracellular protein trafficking using budding yeast as a model system. Her research described a requirement of the Spindle Pole Body (yeast centrosome) for Targeting/Tethering peripheral proteins to the Inner Nuclear Membrane. After earning her PhD, Greetchen started as a postdoctoral researcher at the Nebraska Center for Virology, University of Nebraska at Lincoln, where she got a NIH T32 Postdoctoral Fellowship to conduct studies in reproduction of Human Papilloma Virus.

Professional Experience:
For more than 10 years, Greetchen was a volunteer, part of the administrative team of CienciaPR. At CienciaPR, she participated in numerous projects in science communication, science outreach, and science education. She is the founder and coordinator of CienciaPR's "Borinqueña", the bilingual blog for Hispanic and Puerto Rican Women in Science and Technology. Also, Greetchen is founder and coordinator of the photoblog “Ciencia a tu alrededor”. In 2015, She was the coordinator of "Semillas de Triunfo" (Seeds of Succeed), the first STEM Ambassador Program for middle school girls in Puerto Rico.

Before joining CienciaPR’s staff in 2017, Dr. Díaz was the Grants Program Director at the Puerto Rico Science, Technology and Research Trust. Greetchen was responsible for the implementation of the first local grants mechanism in Puerto Rico with initiatives such as the Science and Technology Research Grants, the Small Research Grants and the Researcher’s Startup Funds. At the Trust, Dr. Díaz also coordinated the outreach activities that include the Research & innovation Meetups, the Forward Research & Innovation Summit and the Forward Grantees Symposium, among many others.

Dr. Díaz has received numerous awards and honors from various organizations such as CROEM Alumni, the University of Puerto Rico, The Ohio State University, ASM, SACNAS, and the Ford Foundation, among others. In 2017, Greetchen was recognized by the Senate of Puerto Rico for her professional achievements and her election to the ASM board of directors. Her work and projects has been featured on local and international media outlets, such as El Nuevo Día, el Vocero, Noticel, Metro, Caribbean Business, News in my Business, Diálogo, Voces del Sur, Periódico La Perla, Microbe, and Scientific American, among others.

ASM Activities:
Greetchen is the President of the Puerto Rico Society of Microbiologists (PRSM), where she previously served as the PRSM’s Board of Director’s secretary, and ASM councilor. The PRSM is the local branch for the American Society for Microbiology (ASM), where Greetchen is currently a member of its Board of Directors.

Candidate’s Statement:
It would be an honor to be able to serve for a second term on the American Society for Microbiology (ASM) Board of Directors in the Early Career At-Large position. I think it is very important that the Board of Directors is diverse and representative for the different sectors of our membership, and I thank ASM for showing leadership in this regard. ASM has a large number of early career professionals and has had various initiatives aimed at the professional development of these members. My commitment is to provide my perspective and experiences as an early career professional to help the ASM leadership accomplish its mission and provide the best opportunities and support for this group. Like many other professional societies globally, ASM has undergone a process of continuous transformation that, in order to be effective, must go hand in hand with the development of the skills and capacities needed to adapt to those changes. The future of the microbial sciences is in the hands of these early career professionals, and it is my desire to be able to help to enhance their contributions through my service on the Board of Directors. Thanks for your support. 

back to top

CPEP Clinical Microbiology Fellow, UNC, Chapel Hill, North Carolina

 ad confused 3

Dr. Levinson completed her Bachelors degree in Microbiology at Northern Arizona University and a Masters in Public Health in Hospital & Molecular Epidemiology at the University of Michigan.  She completed her PhD in Immunology and Infectious Diseases at the Wadsworth Center, in a combined program with the New York State Department of Health and the State University of New York at Albany.  There she studied host-pathogen interaction and her research identified mechanisms by which lipopolysaccharide-specific antibodies mediate protection against Vibrio cholerae.  Following her PhD, she began her training as a clinical microbiologist through ASM’s post-doctoral CPEP program in Medical and Public Health Microbiology at the University of North Carolina.  She participated in the Advanced Bacterial Genetics Course at Cold Spring Harbor Laboratory in 2012 and the Advanced Course in Immunology through the American Association of Immunologists in 2014.

Professional Experience:
Dr. Levinson served on the Public Health Action Support Team (PHAST) at the University of Michigan, where she assisted local health department’s response to outbreaks and investigations. In 2009, Dr. Levinson was awarded the CDC’s Emerging Infectious Diseases (EID) Fellowship and served at the Iowa State Public Health Laboratory.  As a fellow she coordinated the state’s influenza testing and surveillance response during the 2009 H1N1 influenza pandemic.  Throughout her career, she has served as a research mentor to six students and supervised two college interns while at the State of Alaska Environmental Health Laboratory.  She has a passion for science outreach and education and has taught at multiple institutions to students at a variety of levels, ranging from high school to medical residents.  Dr. Levinson has served on the Iowa Food Safety Task Force, presented at STEM conferences, and participated in career panels at local and national meetings. 

ASM Activities:
Leadership: President of ASM Student Chapter- Eastern New York Branch (2014-2016)
Outreach: ASM Live Theater at Microbe 2017- Served on the career panel for the live session entitled “Microbiology Careers: An Insiders’ Guide to Finding a Job?”
Conference Awards:
-       Infectious Diseases Fellows Program Travel Award, ASM Microbe (2017)
-       Best Poster, ASM Conference on Rapid Next-Generation Sequencing and Bioinformatic Pipelines for Enhanced Molecular Epidemiologic Investigation of Pathogens (2015)
-       Student Travel Award, ASM Conference on Rapid Next-Generation Sequencing and Bioinformatic Pipelines for Enhanced Molecular Epidemiologic Investigation of Pathogens (2015)
-       Student Travel Award, ASM General Meeting, Eastern New York Branch (2014, 2015) 

Levinson et al, Vaccine, 2016. PMID: 27773473
Levinson et al, J Immunol Methods, 2015. PMID: 25865265
Levinson et al, Infect Immun, 2015. PMID: 25667263
Manuscripts in Process:
Baranova et al, PLoS One. Submitted May 2017.
Levinson & Gilligan, Clinical Microbiology Newsletter. Submitted March 2017. 

Research Interests:
-       Host-pathogen interaction
-       Integration of next generation sequencing technology in the clinical microbiology and public health laboratories
-       Science policy and updating regulations to reflect modern molecular techniques to meet the needs of epidemiologists, clinicians, and public health laboratorians.

Candidate’s Statement:
It is an honor to be nominated to run for election for the Early Career At-Large position. Serving on ASM’s Board of Directors would allow me to give back to the organization that has helped lay the framework of my career and enabling me to do the same for future scientists.

I joined ASM as a graduate student and have had the privilege to participate at both the regional and national levels.  I served as President of the student chapter of the Eastern NY branch of ASM, where I orchestrated research symposia, career panels and social events aimed at increasing participation of early career scientists.  I have served on ASM committees and task forces at the national level, where I helped to shape the strategic direction of the Society, ensuring that it continues to meet the needs of all ASM members.

My career path encompasses a wide range of microbiology experience, including work in public health, clinical microbiology, and the academic research setting.  If elected to the Early Career At-Large position, I would bring perspective, leadership, and a comprehensive understanding of the priorities of each field within microbiology. I will be an advocate for the next generation of scientists, work to ensure that the Society remains relevant to their needs, and help to retain these members throughout their career trajectory.

The ways in which we conduct, learn, and communicate our science is changing and the mechanisms by which ASM will meet those needs are changing as well.  By serving on the Board of Directors, I can promote the mission and goals of the Society through increased engagement of young scientists.  I remain committed to advancing the microbial sciences and it would be a privilege to serve on the ASM Board of Directors.

 back to top

  Board of Directors, International Scientist - Select One

PhD, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina, Facultad de Medicina, Universidad de Buenos Aires, Argentina



Bachelor of Science – Colegio Gdor. Mariano Saavedra. Master of Science in Genetics – Universidad Nacional del Nordeste (UNNE). Doctor in immunopathology – School of Medicine – Universidad de Buenos Aires (UBA).

Professional Experience:
Dr. Patricio Acosta is an Assistant Professor at the National Scientific and Technical Research Council, CONICET (Argentina) and at the School of Medicine – Universidad de Buenos Aires. He received his MSc with concentration in genetics from the Universidad Nacional del Nordeste and his doctorate in immunopathology from the Universidad de Buenos Aires with the highest honors (summa cum laude). Following his graduate training, he completed a postdoctoral fellowship training program at Fundacion INFANT under the supervision of Dr. Fernando Polack. During 2010-11 he worked as research fellow in the laboratory of Dr. James Crowe Jr. at Vanderbilt University. Since 2011, he has led the team responsible of the laboratory viral diagnoses for a huge study funded (for the first time in Argentina) by the Melinda & Bill Gates Foundation. His work combines the virological laboratory diagnostics and investigation. He has received among other distinctions, awards and recognitions from the Argentine Chamber of deputies, Argentine Senate, Universidad Nacional del Nordeste, the Sociedad Argentina de Microbiología, the Entre Ríos government, the Argentine National Educational Ministry, the International Society of Influenza and Respiratory Viruses, the National Scientific and Technical Research Council, the Macrae Foundation and the International Society for Infectious diseases. Finally, last year he received the Young Investigator Award 2016 from the Pan-American Society for Clinical Virology. On the other hand, he has been engaged in teaching undergraduate courses at the Universidad Nacional del Nordeste, Universidad de Buenos Aires and has also served as mentor in the “Translational Health Science Internship in Argentina”, a program from Georgetown University (USA). Finally, is appropriate to mention that Dr. Acosta is guest editor of Mediators of Inflammation Journal.

ASM Activities:
Since 2013 ASM Science Ambassador, aims to mobilize next generation of scientists to develop innovative approaches to science. Met with different colleagues from Argentina and around the world, including the ASM ambassadors from more than 50 countries. Last 3 years, represented ASM in several meetings and events in Argentina. In 2016, was elected one of 8 members of ASM Young Leaders circle, which delineates science ambassadors program. Finally, this year he was elected as a member of the Board of Directors.

In last 5 years, 14 publications with 5 as first author.

Research Interests:
Dr. Acosta research interests include understanding the pathogenesis of respiratory viruses (RSV, Rhinovirus & Influenza) and the host immune response to viral infection, particularly in low-income pediatric populations. His principal aim is to develop research initiatives that translate laboratory findings into interventions with direct impact on the welfare of children.

Candidate’s Statement:
ASM is a worldwide distinguished institution. I am honored to be chosen to be on the ballot for the ASM BOD. As indicated in my biography, I am a virologist with a research focus in respiratory pathogens. My research interest includes the pathogenesis of respiratory viruses (RSV, Rhinovirus & Influenza) and the host immune response to viral infection, particularly in low-income pediatric populations.

I have been an active ASM member for many years. Most of my volunteer activities for our Society have been within the international area. I was elected ASM Young Ambassador (2013-2016), Young Leader Circle member (2016-17) and Board of Directors member (2017). I am very proud to be part of ASM and feel extraordinarily privileged to be part of the leadership of our Society.

My volunteerism has been the basis of immense satisfaction in my professional life but on the other hand, I have made friends in the five continents, also members of this big family.

I encourage all of you to become active in ASM and take a role in our future because our Society must continue to promote the viability of a scientific discipline that is so important to our health, and to the health of the planet on which we live.

I am truly honored to be invited to stand for election as BOD member of our Society; I am sure that with your support, the success is guaranteed.

 back to top

New Zealand Ministry for Primary Industries, Wellington, New Zealand



Doctor of Philosophy
Master of Medical Science
Bachelor of Science (Biomedical Science)

Professional Experience:
Ron has a wide range of experience in research, clinical diagnostic science, applied science in the food industry, policy and trade. His work ranged from wet-bench research high throughput applied and diagnostic testing, development and implementation of food standards, to agricultural and food safety cooperation activities at international levels.

  • Senior Adviser, Policy and Trade Branch, New Zealand Ministry for Primary Industries
  • Adviser, Food Production and Processing, New Zealand Ministry for Primary Industries
  • Scientist, Food and Bio-based Products, New Zealand AgResearch
  • Technician, Diagnostic Molecular Biology, New Zealand Waikato District Health Board
  • Technician, Quality Assurance, Fonterra Chemistry Laboratory

Outside of employment, Ron also holds positions in leadership, governance, communication and diplomacy, including:

  • Director of Communications, New Zealand Asia Pacific Research Institute
    • Led the modernization of membership engagement channels for Asia Forum of Wellington
    • Lead the communication strategy for the Asia Forum of Wellington membership and public engagement
  • Leadership Network Member, Asia New Zealand Foundation
    • Involved in non-official diplomacy channels through science cooperation and cultural exchanges

ASM Activities:
ASM member since 2009

  • Served two terms as the ASM Young Ambassador of Science to New Zealand (2013-2017)
  • Member of the ASM Futures Project (2014-2016)
  • Member of the ASM Young Leader Circle (2015-2017)

Effect of Long-Term Starvation on the Survival, Recovery, and Carbon Utilization Profiles of a Bovine Escherichia coli O157:H7 Isolate from New Zealand. Appl. Environ. Microbiol. July 2014 vol. 80 no. 14 4383-4390.

Early-career scientists on careers, communication, and policy making. ASM Cultures Magazine. January 2014 vol. 1 issue 1 40-49.

Research Interests:
Ron’s passion is to bring together technical, policy and commercial perspectives to achieve material results with measurable impact. His latest interest is in exploring cooperation opportunities at international level to advance technological development and exchange as well as diplomatic outcomes. This includes scientists/technical personnel exchange, educational programs, and technical comparison of regulatory requirements.

Candidate’s Statement:
The ecosystem of science is changing at a global level, and with it come new challenges for ASM members all over the world.

Ron’s wide-ranging experience in science and related industries gave him the unique perspective and skillset to solicit, communicate and represent the varying needs of ASM members working in different fields

He brings to this position the willingness to listen and learn, the skills to communicate the perspectives of many, and the governance and leadership experience to support the operational needs of the ASM Board of Directors.

Ron started in ASM as a passive international member with little understanding of the breadth and depth of the society. The ASM Young Ambassador of Science program not only changed his career path, the program connected him to fellow Young Ambassadors and Senior Ambassadors in the global ASM family and the voices of ASM international members.

Through engaging with ASM international members with diverse cultural backgrounds in different science systems, Ron understands that all ASM members have the same basic needs of being supported and represented by a society that advances their career in the ever-changing world of science.

From a passive student member to an active participant in shaping the future of ASM though the Futures Project, Ron experienced first-hand the evolution of the society. Now his passion is to serve the society on its journey to continue the long ASM tradition of nurturing, developing and representing its members around the world.


Council on Microbial Sciences, Early Career Scientist - Select One

Discipline-Based Education Research (DBER) Fellow, University of California, Los Angeles



2017 Ph.D. in Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles; 2011 B.S. in Molecular Biology, University of California, San Diego

Professional Experience:
2017-Present DBER Fellow – Develop undergraduate introductory life sciences curriculum, teach undergraduate introductory biology courses, collect data on efficacy of interventions meant to enhance student learning and promote equity and retention in STEM majors at UCLA; 2016-2017 Teaching Assistant Consultant, University of California, Los Angeles - Organized workshops and two UCLA courses to train new TAs and familiarize them with active learning techniques; 2016-2017 Staff Writer, Signal to Noise Magazine; 2016-2017 Vice President, SciComm Hub @ UCLA; 2014 STEAM Carnival outreach facilitator, 2014 Student Mentor, CityLab at UCLA

ASM Activities:
2017-Present Early Career Scientist Representative for Council on Microbial Sciences (COMS); 2017-Present ASM Communications Committee Member; 2017-Present Contributing Author, Microcosm Magazine; 2015-2016 Contributing Author, Microbe magazine; 2016 Poster presentation at ASM Microbe Conference; 2014 Poster presentation at ASM General Meeting

Selected Publications:

Maloy, Jeffrey P. “Branches and Chapters: ASM at the Local Level.” Microcosm Magazine. 1.3 (2017). In press.

Maloy, Jeffrey P. “ASM Member Profiles.” Recurring feature in Microcosm Magazine 1.1-1.3 (2017). Print.

Maloy, Jeffrey P. "Different Strokes: Blending Microbiology and Art." Microbe Magazine 11.12 (2016): 421-26. Print.

Maloy, Jeffrey P. "I, Cannibal: The Critical Role of Autophagy In Human Physiology." Signal to Noise. 4 Oct. 2016. Web.

Maloy, Jeffrey P. “Hard to Swallow: Outbreaks at Chipotle Restaurants Mimic Broader Patterns of Foodborne Illness in the United States.” Signal to Noise. 4 March 2016. Web.

Erickson, Stacy L., Elizabeth O. Corpuz, Jeffrey P. Maloy, Christy Fillman, Kristofer Webb, Eric J. Bennett, and Jens Lykke-Andersen. "Competition between Decapping Complex Formation and Ubiquitin-Mediated Proteasomal Degradation Controls Human Dcp2 Decapping Activity." Molecular and Cellular Biology 35.12 (2015): 2144-153. Web.

Research Interests:
As a discipline-based education research fellow, my research is focused on understanding the factors that maximize learning gains and promote retention of a diverse group of undergraduate students in life sciences majors. Specifically, I am currently focused on understanding how interesting anecdotes, or “seductive details,” that instructors commonly insert into lectures impact student learning, interest, and self-efficacy.

Candidate’s Statement:
During the year I have served as the Early Career Scientist Representative on COMS, I have taken on a variety of roles that will help undergraduate, graduate, postdoctoral, and other early career microbial scientists interested in broadening their experience and advancing their careers.

One major advantage of the new governance structure of ASM is the amplification of diverse voices within the ASM membership, including the voices of younger microbial scientists. Based on survey data that ASM has collected, it is clear that there is a real need for more and richer opportunities for career exploration and mentoring opportunities for early career members. Over the past year, I have been closely involved in the development of a career mentoring program that ASM hopes to pilot in the coming year and will subsequently make available to a broad range of early career scientists. If I am elected to another term on COMS, I hope to continue this effort and make this a resource that will provide important career assistance and add value to ASM membership for a wide variety of microbial scientists.

In addition to my efforts to enhance career mentoring opportunities at ASM, I have been involved in a variety of other efforts to expand the appeal of ASM by enhancing outreach to members with diverse careers and interests. As a member of the Profession of Microbial Sciences (POMS) track on COMS, I have worked with other councilors to identify some important opportunities for ASM to assist members in connecting across traditional disciplinary and career boundaries. I am also currently a member of the ASM communications committee, where I am working alongside other ASM members to ensure that all of our members and potential members are aware of the incredible array of resources and opportunities that ASM already provides. Finally, over the past two years I have been a regular contributor to Microbe Magazine and Microcosm Magazine, where I have written profiles of ASM members, a piece on ASM local branches and chapters, and an article about the intersection of microbiology and art.

In summary, I believe that I am a uniquely qualified and engaged early career scientist in an excellent position to champion the diverse interests and needs of other early career ASM members and potential members. During the year that I have served on COMS, I have solicited and received input from many early career scientists regarding how ASM can better serve their needs, and many of my efforts described above have been informed by that input. If I am chosen to serve another term as the Early Career Scientist Representative on COMS, I will continue my efforts to listen to early career ASM members, develop a formal mentoring program, and enhance outreach and communication efforts that will benefit not only early career members, but also the ASM membership as a whole.

back to top

PhD, D(ABMM), Assistant Professor of Pathology, Johns Hopkins University School of Medicine, and Director of Medical Bacteriology and Parasitology Laboratories, Johns Hopkins Medical Institutions, Baltimore, MD


She completed her undergraduate and graduate studies at the University of Manitoba in Manitoba, Canada and a two year Clinical Microbiology Fellowship at the Mayo Clinic in Rochester, MN.  Dr. Simner is a certified Diplomate of the American Board of Medical Microbiology.

Professional Experience:
Dr. Simner is a member of the Subcommittee on Antimicrobial Susceptibility Testing for the Clinical and Laboratory Standards Institute, a member of the American Board of Medical Microbiology exam validation committee for the American College of Microbiology and a member of the Antimicrobial Resistance Surveillance Taskforce for the Centers for Disease Control and Prevention (CDC).

ASM Activities:
Dr. Simner has been an ASM member since 2006.  She has contributed to ASM by serving as an editorial board member for the ASM Journal of Clinical Microbiology and by writing chapters for ASM press books. She has also acted as an abstract reviewer for the ASM General Meeting & Microbe meetings and an ASM representative on the FDA-CDC led endoscope culturing guidelines committee.

For a young researcher, she is well published with greater than 60 peer-reviewed manuscripts and 9 book chapters. She has also presented her research at local, regional, national and international conferences.

Research Interests:
Her research has focused on understanding the epidemiology and molecular mechanisms of resistance of Gram-negative bacteria, in particular those harboring β-lactamase enzymes. With the increasing prevalence of carbapenemase-producing organism (CPO), her focus has evolved to studying novel diagnostic methods for the detection of these clinically important pathogens and understanding their mechanisms of resistance and spread in the hospital setting.  Dr. Simner is currently the principal investigator for a National Institute of Health (NIH) grant which seeks to understand the molecular mechanisms of antibiotic resistance and spread amongst all CPO in a region of the US endemic for CPO.  In addition, she is involved in many interdisciplinary collaborative research projects, including a Centers for Disease Control and Prevention (CDC) Epicenter grant and a NIH R01 subaward with the University of Michigan.  She is also interested in novel diagnostic tools for infectious diseases and is actively involved in validating metagenomic next-generation sequencing as a diagnostic tool.

Candidate’s Statement:
It is with great excitement and honor that I stand for nomination for the ASM Council on Microbial Sciences as the Early Career At-Large Representative. ASM is the premier society that represents our academic interests and the Council on Microbial Sciences helps to establish the scientific direction of the society for our members. I am well qualified to stand for this position, for multiple reasons that I outline below. Currently, I hold a combined clinical and research appointment in a large hospital based-academic medical center, allowing me to represent both aspects of our community at large.  As a clinical microbiologist, I am interested in novel diagnostic tools for infectious diseases and I currently spear-head the applications of next-generation sequencing in the diagnostic laboratory.  This experience is beneficial to the community as next-generation sequencing technology broadly impacts many of the tracks that fall under the COMs umbrella. In addition, I understand the issues currently affecting the clinical scientists in our community.  As a researcher, I study the molecular mechanisms of antimicrobial resistance and spread of multidrug-resistant pathogens with emphasis on carbapenem-resistant Gram-negative organisms.  I am well published in these areas with greater than 60 peer-reviewed manuscripts and 9 book chapters. As we enter an era where microbial pathogens have successfully evaded most of the antimicrobials in our arsenal, we need to pursue high quality research from many different fields to overcome this critical problem. Currently, I’m the principal investigator for a NIH award and I am involved in multiple interdisciplinary collaborative research projects addressing this global issue, including a CDC Epicenter grant and a NIH R01 subaward with the University of Michigan. These translational studies have the potential to impact infection control and antimicrobial stewardship guidelines while providing the basis of understanding at a molecular level of how these organisms develop resistance and spread in the hospital setting. As a researcher, I understand the importance of funding sources to fuel our scientific programs and educational tools to advance our scientific knowledge. Additionally, I have been an ASM member since 2006 starting as a graduate student, then as a postdoctoral fellow and now as a faculty member with an academic appointment, which will contribute to my understanding of the various levels of membership that I will be representing. As a member I am/have contributed to our society by serving as an editorial board member for the ASM Journal of Clinical Microbiology and by writing chapters for ASM Press books. I have been an abstract reviewer for the ASM General Meeting & Microbe meetings and I represented ASM on the FDA-CDC led endoscope culturing guidelines committee. I have been fortunate to be a recipient of travel awards from ASM while I was a student and I was recently named the recipient of the ASM 2018 Diagnostics Young Investigator Award. I look forward to further contributing to our wonderful society by being the voice of my peers to help shape the future of ASM. This position is an ideal opportunity for me to fulfill my desire to build upon my contributions by advancing the future direction and scope of our society.

back to top

Council on Microbial Sciences, International Scientists - Select Two

FRS, Professor, Department of Biochemistry, University of Oxford, Oxford, UK


BSc (hons) University College London; PhD in Microbiology University College London

Professional Experience:
University of Oxford: Lecturer (1985) and the full professor (1996) in Bacterial Biochemistry


  • 1995 Elected Fellow, Lister Institute
  • 1997 Elected Fellow, University College London
  • 2004 Elected Chair, Gordon Conference (STIM)
  • 2004 Elected Chair, ESF Conference in Bacterial Neural Networks
  • 2010 Elected Member EMBO
  • 2011 Faculty of 1000, Co-Head Microbial Growth and Development section
  • 2011 Elected Fellow, American Academy of Microbiology
  • 2011 Elected Fellow, Royal Society of Biology
  • 2013 Elected Fellow of the Royal Society
  • 2015 Elected Member of European Academy of Microbiology
  • 2015 Governor and Trustee Lister Institute 2015-2020


  • Published ~200 papers since 1974
  • Presented ~125 invited lectures at international conferences and workshops
  • Organised and/or Chaired 17 conferences.
  • 50+ Overseas, 50+ UK invited seminars.
  • Supervised 40+ students to the degree of PhD and trained 30+ postdoctoral scientists;
  • Uninterrupted external support of research programme from 1982:
  • Director OCISB 2006-2012 (£8.4m)
  • Co-PI Systems Biology DTC (~£4m) and Synthetic Biology CDT


  • Netherlands Expert panel on Systems Biology 2008-2010
  • Wellcome Trust MGC Committee 2009-2011
  • Human Frontiers of Science Programme: Council of Scientists, 2008-2012
  • BBSRC Enhancing Photosynthesis Panel Chair 2010-2011
  • Governing Council, John Innes Research Centre, 2009-2011
  • German Federal Ministry of Education, Systems Biology Advisory Group 2011-2013
  • Advisory Council of the Dutch NCSB program 2010-2014
  • Scientific Advisory Board, John Innes Research Centre, 2010-2016
  • Advisory Committee of Swammerdam Institute, University of Amsterdam, 2002-2010
  • Advisory Board, Max Planck Institute for Terrestrial Microbiology, 2005-2010
  • Advisory Board, Netherlands Consortium for Systems Biology, 2010-2014
  • Advisory Board, Microsoft Research, University of Trento, 2007-2010
  • Advisory Board, Systems Centre, University of Freiburg 2008-2014
  • Programme committee ASM Annual meeting, 2012-16
  • Governor and Trustee Lister Institute 2015-2020
  • Review of Life Sciences, University of Amsterdam and Frei University 2017


  • Associate Head of Department (Microbiology and Systems Biology) 2006-present
  • Graduate Committee, Biochemistry (2010-present)
  • Management Committee Systems Biology DTC 2006-present
  • Management Committee Synthetic Biology CDT 2015-present
  • Sub-Warden, Merton College Oxford 2016-2018


  • Editor in chief: Current Opinion in Microbiology 2016-2020
  • Editor: Journal of Bacteriology 2005-2015
  • Editorial Advisory Boards: Molecular Microbiology 2002-2007.
  • Referee for wide range international agencies, appointments panels and review panels

ASM Activities:

  • Editorial Board: AEM 2000-2005
  • Editor: Journal of Bacteriology 2005-2015
  • Programme committee: ASM annual meeting then Microbe 2012-2017


~200 publications (not all in PubMed)  https://www.ncbi.nlm.nih.gov/pubmed/?term=armitage+jp

Research Interests:
I am a basic bacterial physiologist, interested primarily in how bacteria behave. My main research has concentrated on motility and chemotaxis in a range of species, but this has led to recent studies of the Type 3 Secrection System and chromosome segregation and cell division in the alpha proteobacterium Rhodobacter sphaeroides. I am question rather than technique driven and use a wide range of approaches from molecular genetics through biochemistry to biophysics and state of the art microscopy. Most of my recent work has involved studying protein behavior in living single cells.

Candidate’s Statement:
I became a bacteriologist because of an inspirational biology teacher who persuaded a small school in Yorkshire to buy some microscopes. Once I saw the thriving, interactive microscopic community in a drop of pond water I was hooked, fascinated by how their responses to their world. I have been immensely privileged to spend my career investigating that behaviour.

My first and second degrees are in bacteriology and I have spent my academic career teaching bacterial physiology. I am still driven by a desire to understand how bacteria sense and respond to their environment, but now, rather than watching cells move, I can watch single molecules inside living cells control that movement. The changes in technology during the 40 years of my career have been truly remarkable. I have grasped and used those new technologies, whether microscopes, genetic tools or computational approaches and used them to both “see” inside the living bacterial cell to observe the complex dynamics of interactions and expression patterns and to look outside at population and species interactions and their interplay with the wider biological and physical worlds.

However, we need to ensure that the drive to use exciting new approaches does not overshadow the continued need to understand and appreciate that it is all underpinned by biochemistry and physiology. I continue to fight for the teaching of basic bacterial physiology and biochemistry and the evolution of chemistries that allow bacteria to live in really exciting environments. That said I am not a reductionist. I want to understand how the multiple biochemical pathways expressed and controlled by environmental signals result in the observed behavior of single cells and population.

I am concerned about the increase in expensive technology driving the direction of our science. High profile journals want increasingly exclusive images. These can both skew the definition of “important” and move the focus to big labs and big equipment, resulting in self-fulfilling results. We need to ensure that not all important developments come from the big labs with the big kit and champion the view that really important understanding can come from smaller groups doing “clever” experiments, often with citizen scientists and often in the wider environment.

The last point links to my other concern, the drive by funding agencies to support research linked directly to exploitable outcomes, very often disease. The vast majority of bacterial species are not pathogens, but they are essential for the wellbeing of almost all of the planet. It is now evident that, for example, soil is key to crop success, and depends on the bacterial and fungal communities in the rhizosphere. Similarly water, ocean and built environments respond to their microbial communities. This all links to basic bacterial physiology and responses of different species within communities to change.

I will bring my passion for connecting our developing understanding of bacterial physiology within the biosphere to the position, informed by my roles in the European Academy of Microbiology and the Royal Society.

back to top

PhD, Professor and Head, Department of Basic Medical Sciences, The University of the West Indies (The UWI), Kingston, Jamaica




BSc(Hons) with double major in Biochemistry & Chemistry. The UWI, Mona, Jamaica. 1989
MPhil     in Biochemistry. The UWI, Mona, Jamaica. 1992
PhD in Microbiology (advisor, Paul N. Levett, PhD). The UWI, Cave Hill, Barbados. 1995

Professional Experience:
1999–2001, Assistant Professor, Department of Biology, Chemistry and Medical Technology, Northern Caribbean University, Mandeville, Jamaica; 2001–2009, Lecturer in Microbiology, Department of Basic Medical Sciences, Biochemistry Section, The UWI, Mona, Jamaica; 2003-present, Graduate Course Coordinator, BAMS6011/BC60B: Understanding Research; 2003-2009, Chair, Staff/Student Liaison Committee, Biochemistry section, The UWI, Mona, Jamaica; 2009-2017, Senior Lecturer, Department of Basic Medical Sciences, Biochemistry Section, The UWI, Mona, Jamaica; 2012-present, Council member, International Society of Infectious Diseases; 2013-present, Member, FMS Sub-Committee for Research, UWI, Mona; 2014-present, Chair, Faculty of Medical Sciences (FMS) Annual Research Conference and Workshop Organizing Committee, The UWI, Mona, Jamaica; 2014-present, Member, FMS Committee for Annual Research Awards; 2015-present, President, West Indies Group of University Teachers (WIGUT) Jamaica; 2015-present, Member, Health Services Committee, UWI, Mona; 2016-present, Head, Department of Basic Medical Sciences, The UWI, Mona, Jamaica; 2016-2017, Deputy Dean, Allied Health, Faculty of Medical Sciences, The UWI, Mona, Jamaica; 2017-present, Professor of Molecular Biology, Department of Basic Medical Sciences, Biochemistry Section, The UWI, Mona, Jamaica.

ASM Activities:
2004-present, ASM member; 2008-2010, Country Liaison for Jamaica; 2010-2012, ASM Ambassador for Central America and Caribbean Basin; 2011, Recognized for outstanding service to the International Board; 2012-present, ASM Ambassador to Jamaica; April/May 2014, ASM Ambassador Task Force (Developed white paper outlining the structure and role of an Ambassador Leadership Circle, whose function was to provide strategic direction/stewardship for the Ambassador Program; to allow the International Board (IB) to effectively leverage the Ambassador network to support related initiatives; and to facilitate international volunteers to serve on other ASM leadership bodies); 2014-2016, Appointed member and Chair of inaugural Ambassador Leadership Circle (Provided leadership and oversight of ASM’s strategic direction in terms of communication between members and Ambassadors, international grants and fellowships, and Ambassador Orientation); 2014-2015, Chair, Evaluation Committee for Country Ambassadors (Oversaw the review and appointment of 25 new Ambassadors in October 2014 and 33 new Ambassadors, incl. an Ambassador Council to India in November 2015; 2014-2015, Member, Membership Board Task Force, which was established to review the tiered membership system; 2014-2015, Member of the review committee for the Makela Cassell Travel Award sponsored by FEMS; 2015-2016, Member, International Board; 2017-present, Member and Vice-Chair, Council on Microbial Sciences.

57 peer-reviewed publications, review articles, conference proceedings or book chapters.

Research Interests:
My laboratory has been involved in two main aspects of research: Molecular mechanisms of Leptospira pathogenesis, and antibiotic resistance gene regulation in bacterial of public health interest.

There is a reported 27/100,000 incidence rate for leptospirosis in Jamaica, where two endemic Leptospira strains are responsible for most of the human seroconversions. Current research underway involves identification and characterization of Leptospira virulence-associated genes that are regulated by environmental parameters in challenging the hypothesis that expression of virulence in Leptospira interrogans Portlandvere is more responsive to changes in temperature, oxidative stress and iron limitation than for Leptospira borgpetersenii Jules. The antibiotic resistance patterns and mechanisms of pathogenicity are being investigated in clinical isolates of Pseudomonas aeruginosa, Staphylococcus aureus (including MRSA), uropathogenic E. coli (UPEC) and Klebsiella pneumoniae. Our efforts have yielded fruit in terms of confirming the role of DNA adenine methylase in the epigenetic regulation of quinolone resistance and P fimbriae expression in UPEC, and virulence attenuation in Staphylococcus aureus using short RNAs using a Caenorhabditis elegans model. Currently, we are investigating the role of the stringent response in stress tolerance and antimicrobial resistance in K. pneumoniae and its contribution to in vivo pathogenesis.

Candidate’s Statement:
I am honored to be a nominee to continue to serve on the ASM Council on Microbial Sciences (COMS). These past several months have been a great experience as we have started to put some structure to the fledgling COMS. As Vice-Chair of COMS, I have had the opportunity to interact closely with so many others, who, like me, are deeply passionate about the potential for even further growth and development of ASM. While this growth and development take place, I am mindful that the diverse membership of ASM require special care to maintain the vibrancy and broad perspective needed for ideation and promotion of solutions to current and future problems in Microbiology. I feel I am well placed to lead in this capacity.

As a basis, my extensive experience in ASM have included: service as Ambassador for Central America and Caribbean Basin (2010-2012), service as Chair of the inaugural Ambassador Leadership Circle (ALC; 2014-2016), and service as Country Ambassador to Jamaica (2012-2017). During this time, I worked as part of the International Board and provided leadership and oversight for ASM’s strategic direction in terms of communication between international members and Ambassadors, international grants and fellowships, and the appointment and orientation of over 40 Country Ambassadors. Educational outreach in Universities, poster prizes at local conferences, and interaction with sister microbiology societies have been features of my tenure over the past several years.

Since 2014, I serve as President of the West Indies Group of University Teachers (WIGUT), a registered Trade Union which has members in 15 Caribbean countries, so I bring to the position negotiation and advocacy skills. Further, as Head of the Department of Basic Medical Sciences at The University of the West Indies and Professor of Molecular Biology, I have been able to excite both undergraduate and graduate students about science in general and the microbial sciences in particular. All of these positions have significant managerial and financial responsibilities, which will undoubtedly assist in the effective guiding of decisions and recommendations to be made by the COMS.

back to top

Dr. (PhD, PhD), Erasmus University Medical Center Rotterdam (Erasmus MC), Rotterdam, Zuid Holland, the Netherlands.




PhD - 'The Genetic Diversity and Complement Resistance Phenotype of Moraxella catarrhalis’.
Erasmus MC, Rotterdam, the Netherlands. 2000 - 2005.
PhD - 'The Molecular Epidemiology of Human Coronavirus 229E'.
University of Leicester, Leicester, UK.  1993 – 1996.  
MSc (with Distinction) - Biomedical Science.
Nottingham Polytechnic, Nottingham, UK    1990 – 1992.
BSc - Biology with Food Science and Nutrition.
Oxford Polytechnic, Oxford, UK    1983 – 1986.

Professional Experience:
European Union-Funded International Research

Coordinator   -

  • 'Tailored Antimicrobial Treatment Regimens' (www.tailored-treatment.eu).
  • 'New Anti-Bacterials' (www.nabarsi.eu).
  • 'An Integrated Tool-Kit.' (www.tempotest-qc.eu).

Principle Investigator -

  • 'Diagnosis for Personalized Monitoring and Treatment' (www.diagoras.eu).
  • 'Nanotherapeutics to Treat Antibiotic Resistant Gram-Negative Pneumonia' (www.pneumonp.eu).
  • 'Novel Prevention and Treatment for Otitis Media' (OMVac).
  • ‘Mobile Genetic Elements in Antimicrobial Drug Resistance (DRESP2).

Co-Investigator -

  • Clinical Decision Support Platform for Pancreatic Cancer (Eurostars)
  • Joint Programming Initiative on Antimicrobial Resistance (JPIAMR )


Clinical Scientist Grade B15
Enteric and Respiratory Virus Laboratory, CPHL, London, UK. 1998 – 1999.
Higher Scientific Officer 
Virology and Molecular Methods Group, CSL, York, UK. 1997 - 1998.
Medical Laboratory Scientific Officer 
Microbiological Diagnostic Laboratory, QMC Hospital, Nottingham, UK. 1987 - 1993

BSc (3x) - 'Clinical Medicine', 'Clinical Technology', 'Life Sciences’.
MSc - 'Infection and Immunity'.
6 PhD students.


1) Scientific Advisor - to a Member of the European Parliament.

2) Scientific Board - Omnigen BV (www.omnigen.nl/en/about-omnigen-2/)

3) European Scientific Advisory Board - GenePOC Inc. (www.genepoc-diagnostics.com/about/)

ASM Activities:
Experience as an 'International At-Large' representative in the inaugural (2017) ASM Council on Microbial Sciences (COMS). Involved in debating the structure and future direction of ASM.  The structure of COMS is still being molded and I feel that the mandatory 1 year term has been insufficient for me to fully contribute my ideas and opinions to ASM. Therefore, I am seeking re-election.

62 Publications in Scientific Journals  e.g.

1) Why is scientific research on ‘data-poor’ microorganisms being ignored? John P. Hays.
     Future Microbiology. May 2017 doi:10.2217/fmb-2017-0061.

2) Current problems associated with microbiological point-of-care testing of respiratory tract  
     infections in primary care. Future Microbiology. 2016. doi 10.2217/fmb-2015-0020.

3) Novel micelle PCR-based method for accurate, sensitive and quantitative microbiota profiling.
    Sci Rep. 2017. doi:  10.1038/srep45536.

6x Book Chapters  e.g
“The Genus Moraxella.”. 2005. Dworkin et al. (Eds.) ISBN: 978-0-387-25496-8.

2x Authorships of Books e.g.
1) Principles and Technical Aspects of PCR Amplification. 2008. ISBN 978-4020-6240-7.

1x Book Editor
New Technologies in Medical Microbiology and Diagnosis. 2012. eISBN: 978-1-60805-316-2.

Research Interests:
My research interests have been varied, ranging from the pathogenesis of (bacterial and viral) respiratory tract pathogens to antibiotic resistance and molecular microbiological diagnostics. Though, I have not followed the path of a 'typical' scientist during my career, my broad experience is allowing me to generate new synergies between my research interests and (for example) colleagues in the fields of bioinformatics and microbiota research.

Candidate’s Statement:
ASM is the leading global authority on policy, research, teaching, training, diagnostics and professional standards in microbiology. However, in order to maintain its leading position, the society needs to continually assess the performance of its current strategies, whilst look to the future in order to predict and pro-actively adapt to changing microbiological trends at the global level.

In this respect, I foresee that the ASM's major areas of focus will continue to be the fostering of worldwide monitoring, training, teaching  and research programs to combat global infectious disease endemics and epidemics and antimicrobial  resistances—including antiviral, antifungal, antiparasitic and antibacterial infections. However, further advances could be made in developing communications with small and large companies, creating new online educational packages (including Massive Open Online Courses - MOOCS) and exploring new intersections between contrasting areas of scientific research with microbiology.

Looking to the future, I see a pressing requirement for continuing ASM contributions towards the development of non-partisan infectious disease policy documents and research relating to (for example) the effect of extreme weather, mass migration and environmental pollution on human and animal health at the global scale.  For example, think about the recent extreme weather conditions (hurricanes, drought, etc.) experienced in the USA and across the world. Also, note the recent outbreak of cholera in Yemen (the largest ever recorded!). ASM should be a leader in proactively promoting the development of integrated global microbiological research plans, possibly via promoting joint funding opportunities and collaborative roadmaps between international funding bodies, as well as promoting research on new antibiotics, vaccines and diagnostics.

These are some of the suggestions that I think will help maintain and promote ASM as a leader and the trusted global source for information in the field of global microbiology.

 back to top

Director and full professor of the Institute of Molecular Infection Biology (IMIB), Acting director of the Helmholtz Institute for RNA-based Infection Research (HIRI), Würzburg, Germany


1999                        Dr. rer. nat., Humboldt University, Berlin, Germany
1997                        Diplom Biochemistry, Humboldt University
1994                        Undergraduate Biochemistry, Imperial College London, UK

Professional Experience:
2017 - present       Acting director, Helmholtz Institute for RNA-based Infection Research, Würzburg, Germany
2009 - present       Director and Full Professor, Institute of Molecular Infection Biology, University of Würzburg, Germany
2004 - 2010           Max Planck Research Group Leader, MPI for Infection Biology, Berlin, Germany
2002 - 2003           EMBO Fellow, Hebrew University, Hadassah Medical School, Jerusalem, Israel
2000 - 2001           Postdoc, Department of Cell & Molecular Biology, Uppsala University, Sweden

ASM Activities:
Elected fellow of the American Academy of Microbiology (2013)
Organizer of the ASM conference on “Regulating with RNA in Bacteria” (2011)
Symposium Chair “Beyond the Central Dogma: Diversity in Regulation of Gene expression” (2012)

Westermann AJ, Förstner KU, Amman F, Barquist L, Chao Y, Schulte LN, Müller L, Reinhardt R, Stadler PF, Vogel J (2016)
Dual RNA-seq unveils noncoding RNA functions in host-pathogen interactions
Nature 529:496-501

Smirnov A, Förstner KU, Holmqvist E, Otto A, Günster R, Becher D, Reinhardt R, Vogel J (2016)
Grad-seq guides the discovery of ProQ as a major small RNA binding protein
PNAS 113(41):11591-6

Papenfort K, Sun Y, Miyakoshi M, Vanderpool CK, Vogel J (2013)
Small RNA-mediated activation of sugar phosphatase mRNA regulates glucose homeostasis
Cell 153:426–437

Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J, Charpentier E (2011)
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
Nature 471(7340):602-7

Sharma CM, Hoffmann S, Darfeuille F, Reignier J, Findeiß S, Sittka A, Chabas S, Reiche K, Hackermüller J, Reinhardt R, Stadler PF, Vogel J (2010)
The primary transcriptome of the major human pathogen Helicobacter pylori
Nature 464(7285)250-255

Research Interests:
My laboratory of RNA Biology at the IMIB is interested in the discovery and functional characterization of small RNAs in pathogenic bacteria as well as of microRNAs and long noncoding RNAs in infected eukaryotic host cells. We use global approaches including deep sequencing, to identify regulatory RNAs and their targets, and biochemical and genetic analyses to decipher new molecular mechanisms and physiological consequences of RNA-based regulation.

With the recent foundation of the HIRI in May 2017, we are now extending the scope of the IMIB by establishing the first research institution worldwide that bridges the areas of RNA research and infectious diseases.

Our major goals at the HIRI are:

  • Resolving the complexity and heterogeneity of infection processes at the single-cell level
  • Identifying novel regulatory RNAs with essential roles in pathogenesis
  • Understanding RNA-based mechanisms in virulence and host defence
  • Developing innovative delivery techniques for RNA-based interventions
  • Exploiting RNA knowledge for new diagnostics, preventives and anti-infectives

Candidate’s Statement:
I am delighted to have been selected for the ballot as At-large Councilor of the ASM. I would be honored to join the COMS because I view it as a splendid opportunity to support the BOD by spreading the voice of my peers and to promote the field of RNA research in microbes.


 back to top